Abstract:Objectve To investigate the effect of resveratrol on the proliferation of glioblastoma resistant to temozolamine (TMZ) and the relationship between cell cycle and drug resistance genes expression.Methods U87 cell line was adopted to induce TMZ glioma model (U87-TMZ) by increasing the concentration of temozolomide.Methyl thiazol tetrazolium (MTW) assay was used to detect the proliferation of drug-resistant cell lines.Flow cytometry was used to detect the change of U87-TMZ cell cycle by resveratrol.Western blotting was used to detect the expression of Cyclin D1,topoisomerase (TOPO Ⅱ) α,glutathione-s-transferase (GST)-π,O6-methylguanine-DNA-methyltransferase (MGMT),and P-glycoprotein (P-gp).Results U87 glioma cells were stably stimulated with 20 μg/ml temozolamine for 6 months,and the U87-TMZ model was successfully constructed.Compared with the control group (DMSO group) and the blank group,the inhibition of proliferation of glioma cells was significantly decreased in 24 h in U87-TMZ model treated with 40 μg/ml resveratrol (experimental group) (P =0.014).Resveratrol inhibited the U87-TMZ cell cycle in a different period as compared with the control group,resulting in prolongation of the G1 phase and a decrease in the division phase.Western blotting analysis showed that resveratrol had different expression of drug resistance genes.The expression of Cyclin D1,TOPO Ⅱ α,GST-π and MGMT proteins was significantly decreased in U87-TMZ group (experimental group) as compared with U87 group (P =0.002,0.007,0.031).Before and after treatment with resveratrol in the U87-TMZ group (experimental group),the expression of P-gp gene was not significantly different (P =1.043).The content of Cyclin D protein in U87-TMZ group was related to the change of resveratrol resistance genes.After up-regulating the expression of Cyclin D,the expression of TOPO Ⅱ α,GST-π,MGMT and P-gp was statistically significantly increased (P =0.001).Conclusion Resveratrol inhibits tumor cell proliferation by affecting the expression of Cyclin D protein and regulating U87-TMZ cell cycle.The mechanism may be related to the reduction of the sensitivity of the drug resistance of TOPO Ⅱ α,GST-π and MGMT gene expression.

In vitro study of antitumor effect of levetiracetam combined with temozolomide in glioma cell lines

Antitumor Effect of Levetiracetam Combined with Temozolomide in Glioma Cell Lines.

Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists

Combination of Levetiracetam and IFN-α Increased Temozolomide Efficacy in MGMT-positive Glioma

DRES-07. TMZ-LEV- IFN COCKTAIL REGIMEN SIGNIFICANTLY INHIBITED THE GROWTH OF GLIOMA IN VIVO

Effect of Interferon-Α/β on Temozolomide Activity Against MGMT-positive Glioma Stem-Like Cells in Vitro and in Vivo.

Study on effects of biological activity by temozolomide combined with valproic acid on human glioma cells

Study of chemotherapeutic effects of temozolomide(TMZ) combined with 2-methoxyestradiol(2-ME) on gliomas in vivo in mouse

Synergistic effect of cryptotanshinone and temozolomide treatment against human glioblastoma cells

Effect of Resveratrol on Proliferation of Telmozolamine Resistant Glioblastoma and Mechanism

The clinical observation of temozolomide combined with intensity-modulated radiotherapy in the treatment of malignant glioma with positive MGMT

The effects of the combination of temozolomide and Eribulin on T98G human glioblastoma cell line: an ultrastructural study

Effects of new alkylating agent temozolomide easter on the proliferation of glioma cells

Inhibition Of Elongation Factor-2 Kinase Augments The Antitumor Activity Of Temozolomide Against Glioma

A Clinical Study of Temozolomide in Patients with Malignant Glioma

Effect of p53 targeting small molecule RITA combined with temozolomide on the growth of glioma cells in vitro

Efficacy and Safety of Bevacizumab Combined with Temozolomide in the Treatment of Glioma: A Systematic Review and Meta-Analysis of Clinical Trials

[A Multicenter Randomized Controlled Study of Temozolomide in 97 Patients with Malignant Brain Glioma].

IFN-α/β Enhance Temozolomide Cytotoxic Activity Against Human Glioma in vivo

Metformin and Temozolomide Act Synergistically to Inhibit Growth of Glioma Cells and Glioma Stem Cells in Vitro and in Vivo.

Enhancement of temozolomide-induced apoptosis by valproic acid in human glioma cell lines through redox regulation